Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jin Imai is active.

Publication


Featured researches published by Jin Imai.


Digestion | 2017

Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Takayoshi Suzuki; Aya Masui; Jun Nakamura; Hirokazu Shiozawa; Jun Aoki; Hirohiko Nakae; Shingo Tsuda; Jin Imai; Ozawa Hideki; Masashi Matsushima; Tetsuya Mine; Akira Tamura; Toshihiro Ohtsu; Yukio Asami; Atsushi Takagi

Background: Although there is evidence about the beneficial effects of probiotics, their effects on aspirin-induced small bowel injuries have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri OLL2716 (LG) on aspirin-induced small intestinal lesions, such as ulcers, erosions, reddened lesions, and bleeding. Summary: This study enrolled 64 patients who received aspirin for more than 1 month and provided written informed consent to be part of the study. The patients received 112 ml of yogurt containing LG or placebo twice daily for 6 weeks. Small bowel injuries were evaluated by capsule endoscopy before and after consuming the yogurt. The effect of LG on patient symptoms was also assessed using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (FSSG) and Gastrointestinal Symptom Rating Scale (GSRS) questionnaires before and after 6 weeks of treatment. There was no significant difference in any baseline characteristics and the number of small bowel mucosal breaks between the 2 groups. In contrast with the placebo group, the LG group had significantly fewer small bowel mucosal breaks and reddened lesions after 6 weeks (p < 0.01). The FSSG and GSRS scores were also significantly improved in the LG group but not in the placebo group. Key Messages: This double-blind, placebo-controlled study found that LG may be useful in reducing aspirin-induced small bowel injuries and in mitigating gastrointestinal symptoms.


World Journal of Gastroenterology | 2015

Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.

Takayoshi Suzuki; Masashi Matsushima; Aya Masui; Shingo Tsuda; Jin Imai; Jun Nakamura; Yoko Tsukune; Tetsufumi Uchida; Hiroki Yuhara; Muneki Igarashi; Jun Koike; Tetsuya Mine

AIM To evaluate the efficacy of adding irsogladine maleate (IM) to proton-pump inhibitor (PPI) therapy in non-erosive reflux disease (NERD) treatment. METHODS One hundred patients with NERD were recruited and randomized to receive rabeprazole plus IM (group I) or rabeprazole plus placebo (group P). The efficacy of the treatment was assessed using the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (FSSG) and the short form (SF)-36 quality of life questionnaires after four weeks of treatment. We also assessed whether patients with NERD with minimal changes (grade M) had different responses to the therapies compared with patients who did not have minimal changes (grade N). RESULTS Group I and group P showed significant improvements in their FSSG scores after the treatment (from 17.9 ± 7.9 to 9.0 ± 7.6, and from 17.7 ± 7.3 to 11.2 ± 7.9, respectively, P = 0.0001), but there was no statistically significant difference between the FSSG scores in group I and those in group P. Subgroup analysis showed that significant improvements in the FSSG scores occurred in the patients in group I who had NERD grade N (modified Los Angeles classification) (7.8 ± 7.4 vs 12.5 ± 9.8, P = 0.041). The SF-36 scores for patients with NERD grade N who had received IM and rabeprazole were significantly improved in relation to their vitality and mental health scores. CONCLUSION The addition of IM to rabeprazole significantly improves gastroesophageal reflux disease symptoms and the quality of the lives of patients with NERD grade N.


Internal Medicine | 2017

Non-traumatic Internal Oblique Muscle Hematoma

Jin Imai; Hitoshi Ichikawa; Mariko Sugita; Norihito Watanabe

A 69-year-old obese man (body mass index, 30.3) presented with acute left abdominal pain after severe coughing. He had no history of direct abdominal trauma. He was not receiving anticoagulant therapy. A physical examination showed a smooth painful mass on his left abdominal wall. The laboratory findings were a platelet count of 196,000/ mm and a normal range of coagulability. Ultrasonography revealed a hypoechoic mass in the left lateral abdominal wall (Picture 1a). Unenhanced computed tomography showed a distensible high-density mass consisting of fluidfluid levels in the left internal oblique muscle (Picture 1b and c), and the transverse abdominal muscle was intact. Extravasation could not be evaluated because of his renal dysfunction. He was diagnosed with internal oblique muscle hematoma and was conservatively treated. Ecchymosis presented three days later on his left lateral abdomen (Picture 2). Spontaneous abdominal wall hematoma is considered to occur as a non-traumatic injury to vessels or muscles of the abdominal wall and has several risk factors, including overcontraction due to coughing or vomiting and weakness of the vessel wall as a result of hypertension, arteriosclerosis, obesity or pregnancy (1, 2). In spontaneous ab-


Internal Medicine | 2016

Acute Pleuritis Caused by Mesalamine.

Jin Imai; Takayoshi Suzuki; Shingo Tsuda; Tetsuya Mine

A 28-year-old woman was diagnosed with ulcerative colitis based on colonoscopy findings (Picture 1). Mesalamine (3,600 mg per day) treatment was initiated to treat the patient’s ulcerative colitis. Ten days later, she was admitted our hospital with fever (38.8°C), a dry cough and chest pain. Laboratory tests showed the elevation of the patient’s white blood cell count (13,000/mm) and C-reactive protein level (11.0 mg/dL). Computed tomography (CT) revealed bilateral pleural effusions and patchy consolidations in the peripheral lung fields (Picture 2). At first, ceftriaxone was administered for five days; however, her respiratory symptoms showed continued deterioration. The mesalamine therapy was dis-


Biochemical and Biophysical Research Communications | 2015

Anti-fibrotic effects of a novel small compound on the regulation of cytokine production in a mouse model of colorectal fibrosis.

Jin Imai; Katsuto Hozumi; Hideaki Sumiyoshi; Masaki Yazawa; Ken-ichi Hirano; Jun Abe; Kiyoshi Higashi; Yutaka Inagaki; Tetsuya Mine


Inflammatory Intestinal Diseases | 2016

Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?

Florian Rieder; Jin Imai; Yutaka Inagaki


Internal Medicine | 2014

Liver Abscess Caused by Clostridium perfringens

Jin Imai; Hitoshi Ichikawa; Kosuke Tobita; Norihito Watanabe


Internal Medicine | 2016

Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita

Jin Imai; Takayoshi Suzuki; Marie Yoshikawa; Makiko Dekiden; Hirohiko Nakae; Fumio Nakahara; Shingo Tsuda; Hajime Mizukami; Jun Koike; Muneki Igarashi; Hiromasa Yabe; Tetsuya Mine


Pediatric Dermatology | 2014

A case of pancreatic intraductal tubulopapillary neoplasm (ITPN) mimicking a small ductal carcinoma

Hiroyuki Ito; Jin Imai; Toshinori Yazaki; Hitoshi Ichikawa; Junko Nagata; Seiichiro Kojima; Shinji Takashimizu; Takayuki Shirai; Norihito Watanabe; Misuzu Yamada; Hideki Izumi; Kosuke Tobita; Takuma Tajiri


Internal Medicine | 2014

Radiographic findings of eosinophilic esophagitis.

Jin Imai; Takayoshi Suzuki; Tetsuya Mine; Yutaka Imai

Collaboration


Dive into the Jin Imai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge